PRIMARY STUDY

Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!

Key Findings:  This case report documents a 55-year-old with multiple sclerosis (MS) who, after 4 weeks of adjuvant Sativex, developed behavioral changes, including suicidal ideation. While causation was not clearly established, it does raise concern over concomitant use of cannabinoid products with baclofen and methylprednisolone for MS.

Type of Study:  Meta-analysis

Study Sample Size:  1

Study Result:  Negative

Research Location(s):  Italy

Year of Pub:  2015


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Pharma THC:CBD

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype II

Route of Administration:  Sublingual/Oromucosal




Citation:  Russo M, Rifici C, Sessa E, D'Aleo G, Bramanti P, Calabrò RS. Sativex-induced neurobehavioral effects: causal or concausal? A practical advice! Daru. 2015 Apr 17;23(1):25. doi: 10.1186/s40199-015-0109-6. PMID: 25881038; PMCID: PMC4407789.